DOC-001 / CoA
Semaglutide Certificate of Analysis
These values apply only to the recorded sample and CoA. They are not a future-batch result or a product-wide guarantee.
Acylated peptide API
Semaglutide API Raw Material for Qualified B2B Programs
Semaglutide is a long-acting GLP-1 analogue with 94% sequence homology to human GLP-1. This API page presents the reference molecular identity and sourcing boundary, not a finished dosage form or treatment claim. Supplied form, specification, batch evidence, and target-market eligibility are confirmed per project.
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
- Formula
- C187H291N45O59
- CAS
- 910463-68-2
- Average MW
- 4113.58 g/mol
Product introduction
Semaglutide is a long-acting, acylated GLP-1 analogue with 94% sequence homology to human GLP-1. LUMIRABIO provides an integrated peptide API raw material package covering molecular identity, modification state, supplied form, specification, purity and related-peptide profile, and batch documentation.
Reference identity
Product parameters
Public identity fields organize the first review. Formal specifications and batch records govern the proposed supplied material.
| Parameter | Reference / specification | Source and scope |
|---|---|---|
| Product name | Semaglutide | Supplied form confirmed per project |
| CAS | 910463-68-2 | Named reference identity; formal documents govern the supplied material |
| Formula | C187H291N45O59 | NIH PubChem reference identity Not a batch measurement; counter-ion and supplied form require confirmation |
| Average MW | 4113.58 g/mol | |
| Peptide class | 31 amino-acid residues | Reference sequence identity |
| Portfolio specification | ≥99% by HPLC | Batch-specific result and applicable method per CoA |
| Single impurity / storage | Confirm for the specification and batch | No universal limit or storage-temperature guarantee |
Sequence / structure H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Material definition
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
Packaging and supply handoff
Confirm the supplied form before planning the shipment.
Packaging, storage, documents, eligible U.S. warehouse pathway, destination, and timing are aligned only after the product and batch scope is clear.
- 01
Supplied form
Confirm counter-ion, grade, packaging configuration, and storage conditions.
- 02
Document handoff
Match specification, CoA, analytical support, and shipping records to the proposed batch.
- 03
Regional pathway
Review Los Angeles or New Jersey eligibility; stock, route, release, and timing remain order-specific.
Semaglutide batch-supporting documents
Each entry preserves the sample, method, date, reported result, issuer information, and product mapping of its source record.
DOC-002 / HPLC
Semaglutide HPLC chromatogram
Analysed at 210 nm with manual integration. Peak area is not a content result and is not extrapolated to future batches.
Batch record review
Original records connect the issuer, sample identity, batch, method, date, result, disclosure status, and product mapping in one traceable review.